K2M

Acquired by Welsh, Carson, Anderson & Stowe. Developer of solutions for the treatment of complex spinal pathologies.

Read more

FlowCardia

Acquired by C.R. Bard. Developer of endovascular devices for the treatment of coronary and peripheral CTO.

Read more

Dezima

Acquired by Amgen. Focused on the development of a small molecule therapy for dyslipidemia.

Read more

Conor Medsystems

Acquired by Johnson & Johnson. Focused on the development of drug-eluting stents to treat coronary artery disease.

Read more

Ception

Acquired by Cephalon. Focused on the development of a biologic therapy for the treatment of asthma.

Read more

Biovex

Acquired by Amgen. Focused on the development of an oncolytic vaccine for melanoma and head and neck cancer.

Read more

Therox

Acquired by Zoll Medical. Developer of SuperSaturated Oxygen (SSO2) therapy to complement percutaneous coronary intervention.

Read more

Sensor Platforms

Acquired by Audience. Developer of algorithms and software enabling consumer applications to better understand user contexts and intent.

Read more